Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using hemocoagulase with platelet-rich plasma in hip replacement can lessen blood loss and improve healing and blood clotting.

The FDA rejected a testosterone drug again due to safety concerns.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Most children with skin inflammation taking methotrexate had lab abnormalities, but liver issues often improved without changing the medication dose.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

5α-Reductase helps regulate hormone action in toad testes, especially during breeding season.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

Painful hair loss in an elderly woman was caused by giant cell arteritis, not just aging.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Azathioprine treatment led to rapid hair regrowth in a woman with alopecia universalis.

Rituximab improved her dermatomyositis better than usual treatments.

Both steroids effectively promote hair growth for at least 9 months.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Abrocitinib may effectively treat stubborn alopecia universalis.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Consider necrolytic acral erythema in similar cases and treat with oral zinc sulfate.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

The new treatment effectively heals drug-resistant bacteria-infected wounds.

A new mutation in the XEDAR gene might cause a rare skin condition called hypohidrotic ectodermal dysplasia.